Powered by Blogger.

About me

Contact Form

Name

Email *

Message *

Search This Blog

Blog Archive

Breaking News

Breaking News

Tuesday, April 30, 2019

The obscure advisory committees at the heart of the U.S. drug pricing debate

  Mian Adeel Soomro       Tuesday, April 30, 2019
Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries.


from Reuters: U.S. https://reut.rs/2VwZsGQ
logoblog

Thanks for reading The obscure advisory committees at the heart of the U.S. drug pricing debate

Previous
« Prev Post

No comments:

Post a Comment